» Articles » PMID: 10323772

Presence of Oxidized Low Density Lipoprotein in Nonrheumatic Stenotic Aortic Valves

Overview
Date 1999 May 14
PMID 10323772
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to analyze if LDL particles trapped in stenotic aortic valve tissue undergo oxidative modification. Degenerative aortic stenosis affects >3% of the population >75 years of age in the Western world. Recent studies have revealed the presence of a chronic inflammatory process similar to what has been described in other degenerative diseases such as atherosclerosis. However, the underlying disease mechanisms of degenerative aortic stenosis still remain largely unknown. Six tricuspid stenotic valves, obtained at valve replacement, were compared with 3 control valves collected from hearts taken out during transplantation. The stenotic valves and the control valves were examined by immunohistochemistry, using antibodies against apoB, 4-hydroxynonenal-modified LDL, leukocytes, and HLA-DR. All valves were also stained with oil red O for neutral lipids. Extracellular neutral lipids were found in all stenotic valves, extending from the bases along the fibrosa layer. This lipid colocalized with apoB- and 4-hydroxynonenal-modified LDL immunoreactivity. 4-Hydroxynonenal-modified LDLs were present around calcium deposits, subendothelially, and in the deeper layer of the fibrosa. There was also a colocalization with macrophages, T lymphocytes, and HLA-DR expression. Control valves had a thin area of neutral lipid accumulation, a small amount of apoB, but no signs of inflammation. A distinct colocalization between oxidized LDLs, T-lymphocyte accumulation, and calcium deposits suggests that oxidized lipids may play a role in the disease process.

Citing Articles

In Vitro Models of Cardiovascular Calcification.

Toth A, Balogh E, Jeney V Biomedicines. 2024; 12(9).

PMID: 39335668 PMC: 11429067. DOI: 10.3390/biomedicines12092155.


Development and validation of a prediction model for heart failure in patients with heart valvular regurgitation.

Xiao W, Yuan J, Chen Y, Ma G, Zhang C, Sun L ESC Heart Fail. 2024; 11(5):3242-3252.

PMID: 38923827 PMC: 11424342. DOI: 10.1002/ehf2.14899.


Identifying People at High Risk for Severe Aortic Stenosis: Aortic Valve Calcium Versus Lipoprotein(a) and Low-Density Lipoprotein Cholesterol.

Marrero N, Jha K, Razavi A, Boakye E, Anchouche K, Dzaye O Circ Cardiovasc Imaging. 2024; 17(6):e016372.

PMID: 38889215 PMC: 11423705. DOI: 10.1161/CIRCIMAGING.123.016372.


Reactive Carbonyl Species and Protein Lipoxidation in Atherogenesis.

Negre-Salvayre A, Salvayre R Antioxidants (Basel). 2024; 13(2).

PMID: 38397830 PMC: 10886358. DOI: 10.3390/antiox13020232.


Biomechanical Evaluation of Aortic Valve Stenosis by Means of a Virtual Stress Test: A Fluid-Structure Interaction Study.

Govindarajan V, Kolanjiyil A, Wanna C, Kim H, Prakash S, Chandran K Ann Biomed Eng. 2023; 52(2):414-424.

PMID: 37957528 DOI: 10.1007/s10439-023-03389-6.